| Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. | |
| | |
MedLine Citation:
|
PMID: 19745695 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Because of few cases at any 1 institution, pooling information on the treatment of pregnant women diagnosed with cancer and long-term follow-up of their children is important. METHODS: Women diagnosed with cancer between their last menstrual period and end of pregnancy were voluntarily enrolled in the Cancer and Pregnancy Registry. Details of cancer treatment and pregnancy outcomes were collected. Neonatal follow-up is obtained yearly. RESULTS: Two hundred thirty-one women were enrolled over a 13-year period. Thirteen women elected termination. One hundred fifty-seven neonates were exposed to chemotherapy in utero. Mean gestational age at delivery for neonates exposed to chemotherapy was 35.8 +/- 2.8 weeks, mean birth weight was 2647 +/- 713 g. Six children (3.8%) were born with a congenital anomaly. An intrauterine fetal demise and a neonatal death occurred in 1 case each (0.7% in each). In 12 cases (7.7%), the neonate measured <10% for gestational age at birth. Nine cases (5.8%) delivered spontaneously premature. Sixty-seven women did not receive chemotherapy during pregnancy and delivered 70 neonates. The mean gestational age at delivery was 36.5 +/- 3.3 weeks, mean birth weight was 2873 +/- 788 g. Mean neonatal follow-up is 3 years postpartum and is provided by cancer type and chemotherapy regimen. CONCLUSIONS: In pregnancies exposed to chemotherapy after the first trimester, congenital anomalies, preterm delivery, and growth restriction were not increased as compared with general population norms. Mean gestational age at delivery was not significantly different than neonates who were not exposed to chemotherapy. There was a statistical significant difference in the birth weight between groups, which may not be clinically significant. |
| | |
Authors:
|
Elyce Cardonick; Aniqa Usmani; Sadia Ghaffar |
Related Documents
:
|
11143925 - Benefits and problems with cloning animals. 11773545 - Neonatal antibody titers against varicella-zoster virus in relation to gestational age,... 21097485 - Radiation protection for pregnant workers and their offspring: a recommended approach f... 14504445 - Chaotic analysis approach in neonatal magneto-encephalography. 20104605 - Abnormal sterol metabolism in holoprosencephaly. 20593945 - Evaluation of behavioural change towards smoking in turkish fathers having 0-1 year old... |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: American journal of clinical oncology Volume: 33 ISSN: 1537-453X ISO Abbreviation: Am. J. Clin. Oncol. Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-06-07 Completed Date: 2010-06-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8207754 Medline TA: Am J Clin Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: 221-8 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Robert Wood Johnson Medical College, One Cooper Plaza, Camden, NJ 08103, USA. Cardonick-Elyce@CooperHealth.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abnormalities, Drug-Induced
/
epidemiology,
etiology Abortion, Induced Adult Antineoplastic Agents / adverse effects*, therapeutic use Antineoplastic Combined Chemotherapy Protocols / adverse effects, therapeutic use Birth Weight Congenital Abnormalities / epidemiology* Female Fetal Death / chemically induced, epidemiology* Fetal Growth Retardation / chemically induced, epidemiology Follow-Up Studies Gestational Age Humans Infant, Newborn Infant, Premature Obstetric Labor, Premature / epidemiology* Pregnancy Pregnancy Complications, Neoplastic / drug therapy* Pregnancy Outcome* Prenatal Exposure Delayed Effects Registries World Health |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Frequent Dose Interruptions are Required for Patients Receiving Oral Kinase Inhibitor Therapy for Ad...
Next Document: Prostate Cancer Modality Time Trend Analyses From 1973 to 2004: A Surveillance, Epidemiology, and En...